White Paper

Top 8 Obstacles In Pharma & Biologics Products Registration & Submission Management

By Patricia Santos-Serrao

Channel Success Blocks

The process for developing a new drug and bringing it to market typically takes 10 to 15 years. That average takes into account one country, such as the United States. Add to the registration and approval process other countries and you can factor in a few more years to that timeline.

The average cost of developing a new medicine is estimated at $2.6 billion, a figure that also covers the cost of failures. Not to be pessimistic, but it’s important to think about failures given that the U.S. Food and Drug Administration (FDA) approves only 12 percent of drugs that undergo clinical trials. Taking all of this into consideration, life science organizations can’t afford any delays in product registrations and overall time to market. As with many industries, time is money.

Based on my 20-plus years of experience in the pharmaceutical industry, I have seen a variety of obstacles that result in delays to registrations, many of which can be avoided using sound business processes and leveraging technology to automate processes. I have identified some of the most common problems below and shared some insights on how best to address them.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: